Insider Selling: Ryan Specialty Holdings, Inc. (NYSE:RYAN) Director Sells 35,000 Shares of Stock

Ryan Specialty Holdings, Inc. (NYSE:RYAN) Director Nicholas Dominic Cortezi sold 35,000 shares of Ryan Specialty stock in a transaction that occurred on Wednesday, January 15th. The shares were sold at an average price of $65.99, for a total value of $2,309,650.00. Following the sale, the director now directly owns 35,609 shares in the company, valued at $2,349,837.91. The trade was a 49.57 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link.

Nicholas Dominic Cortezi also recently made the following trade(s):

• On Monday, January 13th, Nicholas Dominic Cortezi sold 29,466 shares of Ryan Specialty stock. The shares were sold at an average price of $65.06, for a total value of $1,917,057.96.
• On Friday, December 20th, Nicholas Dominic Cortezi sold 91 shares of Ryan Specialty stock. The shares were sold at an average price of $65.00, for a total value of $5,915.00.
• On Wednesday, December 18th, Nicholas Dominic Cortezi sold 35,000 shares of Ryan Specialty stock. The shares were sold at an average price of $65.17, for a total value of $2,280,950.00.
• On Monday, December 16th, Nicholas Dominic Cortezi sold 35,000 shares of Ryan Specialty stock. The shares were sold at an average price of $66.71, for a total value of $2,334,850.00.
• On Friday, December 13th, Nicholas Dominic Cortezi sold 35,000 shares of Ryan Specialty stock. The shares were sold at an average price of $67.39, for a total transaction of $2,358,650.00.

Ryan Specialty Price Performance

Shares of RYAN stock opened at $66.83 on Friday. Ryan Specialty Holdings, Inc. has a 12-month low of $42.21 and a 12-month high of $75.97. The firm has a market capitalization of $17.50 billion, a price-to-earnings ratio of 86.79, a price-to-earnings-growth ratio of 1.12 and a beta of 0.72. The company has a quick ratio of 1.01, a current ratio of 1.01 and a debt-to-equity ratio of 2.40. The firm has a fifty day moving average of $68.13 and a 200-day moving average of $65.80.

Ryan Specialty (NYSE:RYAN) last released its earnings results on Wednesday, October 30th. The company reported $0.41 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.41. The firm had revenue of $604.69 million during the quarter, compared to analysts’ expectations of $602.04 million. Ryan Specialty had a return on equity of 47.90% and a net margin of 10.31%. The company’s revenue was up 20.5% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.32 EPS. On average, equities research analysts forecast that Ryan Specialty Holdings, Inc. will post 1.82 earnings per share for the current year.

Ryan Specialty Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, November 26th. Shareholders of record on Tuesday, November 12th were issued a dividend of $0.11 per share. This represents a $0.44 dividend on an annualized basis and a yield of 0.66%. The ex-dividend date was Tuesday, November 12th. Ryan Specialty’s dividend payout ratio (DPR) is presently 57.14%.

Analyst Upgrades and Downgrades

A number of research firms have recently issued reports on RYAN. Keefe, Bruyette & Woods cut their target price on shares of Ryan Specialty from $79.00 to $77.00 and set an “outperform” rating for the company in a research note on Friday, January 10th. Bank of America boosted their price objective on shares of Ryan Specialty from $75.00 to $84.00 and gave the stock a “buy” rating in a research report on Thursday, October 10th. BMO Capital Markets upgraded shares of Ryan Specialty from a “market perform” rating to an “outperform” rating and boosted their price objective for the stock from $65.00 to $75.00 in a research report on Tuesday, September 24th. Wells Fargo & Company lowered their target price on shares of Ryan Specialty from $68.00 to $64.00 and set an “equal weight” rating for the company in a report on Tuesday. Finally, Barclays lifted their target price on shares of Ryan Specialty from $76.00 to $88.00 and gave the stock an “overweight” rating in a report on Thursday, November 21st. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and six have assigned a buy rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and an average price target of $74.40.

Hedge Funds Weigh In On Ryan Specialty

A number of large investors have recently modified their holdings of the business. Signaturefd LLC boosted its stake in shares of Ryan Specialty by 12.3% during the 3rd quarter. Signaturefd LLC now owns 1,347 shares of the company’s stock worth $89,000 after buying an additional 148 shares during the last quarter. UMB Bank n.a. lifted its stake in Ryan Specialty by 5.2% in the 3rd quarter. UMB Bank n.a. now owns 5,224 shares of the company’s stock valued at $347,000 after purchasing an additional 256 shares during the last quarter. Loomis Sayles & Co. L P lifted its stake in Ryan Specialty by 26.3% in the 3rd quarter. Loomis Sayles & Co. L P now owns 1,373 shares of the company’s stock valued at $91,000 after purchasing an additional 286 shares during the last quarter. Cooper Financial Group lifted its stake in Ryan Specialty by 9.9% in the 4th quarter. Cooper Financial Group now owns 3,808 shares of the company’s stock valued at $244,000 after purchasing an additional 342 shares during the last quarter. Finally, Hollencrest Capital Management acquired a new stake in Ryan Specialty in the 3rd quarter valued at about $25,000. 84.82% of the stock is currently owned by institutional investors and hedge funds.

About Ryan Specialty

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.